Literature DB >> 15965615

Mutation hot spots in the canine herpesvirus thymidine kinase gene.

Shinya Yamada1, Yasunobu Matsumoto, Yasuhiro Takashima, Haruki Otsuka.   

Abstract

The guanine and cytosine content (GC-content) of alpha-herpesvirus genes are highly variable despite similar genome structures. It is known that drug resistant HSV, which has the genome with a high GC-content (approximately 70%), commonly includes frameshift mutations in homopolymer stretches of guanine (G) and cytosine (C) within the thymidine kinase (TK) gene. However, whether such mutation hotspots exist in the TK gene of canine herpesvirus (CHV) which has a low GC-content was unknown. In this study, we investigated mutations in the TK gene of CHV. CHV was passaged in the presence of iodo-deoxyuridine (IDU), and IDU-resistant clones were isolated. In all IDU-resistant virus clones, mutations in the TK gene were observed. The majority of these mutations were frameshift mutations of an adenine (A) insertion or deletion within either of 2 stretches of eight A's in the TK gene. It was demonstrated that CHV TK mutations frequently occur at a limited number of hot spots within long homopolymer nucleotide stretches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15965615     DOI: 10.1007/s11262-005-2206-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  17 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Authors:  S Kit; M Sheppard; H Ichimura; S Nusinoff-Lehrman; M N Ellis; J A Fyfe; H Otsuka
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus.

Authors:  W P Summers; M Wagner; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

4.  A comparative study of the DNA density and behavior in tissue cultures of fourteen different herpesviruses.

Authors:  G Plummer; C R Goodheart; D Henson; C P Bowling
Journal:  Virology       Date:  1969-09       Impact factor: 3.616

5.  Acyclovir-resistant herpes simplex virus infection due to altered DNA polymerase.

Authors:  A C Parker; J I Craig; P Collins; N Oliver; I Smith
Journal:  Lancet       Date:  1987-12-19       Impact factor: 79.321

6.  Isolation of a herpes virus from a diseased adult dog in Japan.

Authors:  T Motohashi; M Tajima
Journal:  Nihon Juigaku Zasshi       Date:  1966-12

7.  Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?

Authors:  S L Sacks; R J Wanklin; D E Reece; K A Hicks; K L Tyler; D M Coen
Journal:  Ann Intern Med       Date:  1989-12-01       Impact factor: 25.391

8.  Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.

Authors:  C L Talarico; W C Phelps; K K Biron
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

9.  Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.

Authors:  J J Sasadeusz; F Tufaro; S Safrin; K Schubert; M M Hubinette; P K Cheung; S L Sacks
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

10.  Molecular analysis of the thymidine kinase gene of thymidine kinase-deficient mutants of varicella-zoster virus.

Authors:  H Mori; K Shiraki; T Kato; Y Hayakawa; K Yamanishi; M Takahashi
Journal:  Intervirology       Date:  1988       Impact factor: 1.763

View more
  3 in total

1.  In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.

Authors:  G Andrei; D Topalis; P Fiten; C McGuigan; J Balzarini; G Opdenakker; R Snoeck
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

2.  Frequency and fitness consequences of bacteriophage φ6 host range mutations.

Authors:  Brian E Ford; Bruce Sun; James Carpino; Elizabeth S Chapler; Jane Ching; Yoon Choi; Kevin Jhun; Jung D Kim; Gregory G Lallos; Rachelle Morgenstern; Shalini Singh; Sai Theja; John J Dennehy
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

3.  Comparative mutational analyses of influenza A viruses.

Authors:  Peter Pak-Hang Cheung; Igor B Rogozin; Ka-Tim Choy; Hoi Yee Ng; Joseph Sriyal Malik Peiris; Hui-Ling Yen
Journal:  RNA       Date:  2014-11-17       Impact factor: 4.942

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.